Yes. Portable oxygen concentrators (POCs) genuinely raise blood oxygen in people with hypoxemia, and the FDA clears them as prescription devices for that purpose. But "work" splits into three separate questions: does the device deliver oxygen, does that oxygen raise your saturation during real activity, and does it change clinical outcomes? The first is engineering, the second is physiology, and the third is where marketing outruns evidence. This explainer separates all three, because most 900-word reviews collapse them into a single yes.

The Pressure-Swing Mechanism, One Level Deeper

A POC does not store oxygen. It manufactures it from room air using pressure-swing adsorption, a cyclic process with no chemical consumable. Ambient air is compressed to roughly 15 to 25 psi, and the pressurized gas passes through a zeolite sieve bed. Nitrogen's quadrupole moment gives it a stronger affinity for the zeolite's cation sites than oxygen's, so nitrogen adsorbs onto the mineral while oxygen passes through as product gas. A typical concentrator achieves 90 to 96 percent oxygen purity, which the FDA treats as medical-grade for this purpose.

The clever part is regeneration. While one sieve bed adsorbs nitrogen, the other is vented to near-atmospheric pressure, releasing its trapped nitrogen into exhaust. The beds alternate every few seconds indefinitely. This is why a POC needs no oxygen tank, no refill delivery, and no chemical canister. It needs electricity and clean intake air.

Every POC delivers oxygen as pulses, not a continuous flow. A pressure sensor detects the start of inhalation and fires a bolus of 30 to 90 mL, timed to land at the beginning of the breath. That timing matters physiologically. The first portion of each breath reaches the alveoli most efficiently, while the tail of a breath is largely anatomic dead space. Pulsed delivery exploits this, but it also creates the device's biggest real-world vulnerability, covered below.

Plain language: the machine is a small, repeating air filter that traps nitrogen and hands you the leftover oxygen, one timed puff per breath.

What the Numbers Mean: Purity, Pulse Dose, and the Tank Illusion

Continuous-flow oxygen is measured in liters per minute. Pulse-dose POCs are measured in arbitrary "settings" or "levels," usually 1 through 5 or 1 through 10, that do not correspond to liters per minute. This mismatch is a leading source of confusion. A level 2 setting might deliver an equivalent of roughly 0.4 to 1.0 L/min of continuous flow, depending on rate and device, but manufacturers calibrate differently and no universal conversion exists. Never assume settings transfer between brands.

Battery life runs roughly 4 to 12 hours depending on setting, device, and battery size. Weight spans about 3 to 10 pounds across categories. Maximum oxygen purity holds near 90 to 96 percent on most units but can fall with high breathing rates, altitude, and filter condition.

The counterintuitive detail: higher pulse settings do not always mean proportionally more oxygen to the blood. At rapid breathing rates, some devices cannot fire a full bolus on every breath, so minute-volume delivery can plateau or even drop as respiratory rate climbs during exertion. A patient breathing 30 times per minute on a fixed bolus may receive less oxygen per minute than the same patient breathing 15 times per minute. This is why exercise testing, not a spec sheet, is the honest test.

Device type Oxygen source Duration Weight Typical role
Compressed gas cylinder Stored, 100% O2 Hours to days by size 5 to 50+ lb Backup, high-flow rescue
Liquid oxygen Stored, cryogenic Days per reservoir Varies High-flow home base
Continuous-flow concentrator Room air Unlimited with power 30 to 50 lb Home stationary use
Pulse-dose POC Room air 4 to 12 h per battery 3 to 10 lb Portable ambulatory use
Oxygen-conserving device Stored gas Extends cylinder life Light Tank efficiency add-on

Activity, Altitude, and the Saturation Threshold

The clinical target for long-term oxygen therapy is a resting arterial oxygen saturation (SpO2) at or below 88 percent, or a partial pressure of oxygen (PaO2) at or below 55 mmHg, confirmed by arterial blood gas. Medicare and most payers adopt these thresholds. They come from trials showing survival benefit in chronically hypoxemic patients breathing oxygen many hours per day, often 15 or more.

That evidence base does not automatically transfer to POCs. Landmark trials used stationary concentrators and cylinders for continuous-flow therapy. POC equivalence rests on smaller studies of ambulatory saturation, which generally show that correctly titrated pulse-dose devices maintain saturation during walking in most stable patients. The key word is titrated. A prescription written without an in-clinic or home walk test is a guess.

Altitude compounds the problem. At 8,000 feet, barometric pressure is roughly 74 percent of sea level, and the effective inspired oxygen pressure falls proportionally. A POC's pulse volume is fixed by device design, while the patient's demand rises. Some units perform acceptably at moderate altitude in tested patients; others do not. There is no substitution for a high-altitude simulation test or a real ascent trial before travel.

Reconciling thresholds: resting SpO2 of 88 percent or below qualifies for therapy, but the practical goal during activity is usually to keep saturation above 88 to 90 percent. These are different numbers serving different purposes. Qualification is a gate; titration is a target.

Where POCs Fail: Edge Cases and Caveats

Pulse delivery depends entirely on detecting a breath through a nasal cannula. Mouth breathers, shallow breathers, and people with sleep-disordered breathing may trigger the sensor unreliably. During sleep, respiratory patterns change and some patients desaturate even when daytime saturation looks fine. A POC that works on a walk test may fail overnight. Overnight oximetry on the prescribed device is the only way to know.

Demand also outruns supply in specific populations. People who need more than about 3 L/min of continuous flow at rest, or who desaturate quickly with exertion, often exceed what a pulse-dose POC can deliver. That is not device failure; it is category mismatch. High-flow needs generally require a stationary concentrator or liquid system.

Red-flag warnings: No walk test or overnight oximetry before relying on a POC for activity or sleep. Assuming a "level 3" setting equals 3 L/min on any other device. Using a POC during sleep without documented saturation stability. Traveling to altitude or flying without a high-altitude simulation test. Buying a used unit with expired sieve beds or no purity verification. Relying on a single battery with no charged spare on a trip longer than its rated life.

What Actually Separates Reliable Units from Marginal Ones

Sieve bed condition is the hidden variable. Zeolite degrades with moisture and contamination, and purity quietly drops before the device alarms. Filter maintenance is not cosmetic. Intake filters clogged with dust and pet hair reduce both flow and purity, and some users never check them.

Pulse sensitivity varies more than spec sheets suggest. Devices differ in how small a breath they detect and how consistently they fire at high respiratory rates. For a patient near the edge of their demand, this sensitivity can matter more than advertised battery life.

Noise, heat, and portability are real usability factors. A device that is technically adequate but too loud or heavy to carry gets left at home, and an unused concentrator delivers zero oxygen. Adherence is part of efficacy.

There is also a regulatory caveat worth knowing. FDA clearance establishes that a device is substantially equivalent to a legally marketed predicate for its intended use. It does not establish that the device maintains your saturation during your specific activity. That requires individual titration.

A Practical Titration Protocol

The steps below are general education, not a treatment plan. A clinician orders and interprets testing and writes the prescription.

Get a baseline. Have resting SpO2 and, where indicated, arterial blood gas measured and documented by a clinician. Do a supervised walk test. Walk at your usual pace using the POC on the prescribed setting; measure saturation continuously or at short intervals. Adjust settings with clinical supervision until saturation stays at or above your target. Test the hardest thing you actually do, not a corridor stroll. Stairs, hills, and cold air raise demand. Do overnight oximetry on the device if you will use it during sleep. Do a high-altitude simulation test before any trip above roughly 6,000 to 8,000 feet. Carry spare batteries sized to rated life plus a margin, and verify filter condition before travel.

For each step, record the setting, the activity, and the saturation. A titration record is what converts a device from a gadget into therapy.

Old Assumptions and Persistent Misconceptions

The most persistent misconception is that a POC is a portable tank. It is a generator with settings that do not map to liters. The second is that clearing by the FDA means proven equivalence to continuous flow in all situations. It means the device was reviewed for its intended use, not that it replaces every other modality for every patient.

A subtler error is treating pulse dose as equivalent to continuous flow at the same nominal number. At rest, in a stable patient, a well-titrated pulse device often maintains saturation. During exertion and at altitude, the equivalence narrows. The phrase "equivalent to X liters" in marketing is a useful shorthand, not a physiological measurement.

There is also the accumulation problem. Oxygen saturation can look fine while the patient is becoming short of breath, and a pulse device's silence does not mean the patient is adequately oxygenated. Symptoms and saturation both matter.

What the Evidence Does and Does Not Support

POCs reliably produce medical-grade oxygen and, when correctly titrated, maintain saturation during many daily activities in stable hypoxemic patients. That is a real, defensible benefit. The evidence is weaker for outcome claims: no large trial has shown that pulse-dose POCs reduce mortality or hospitalizations the way continuous-flow therapy did. The mortality benefit established in long-term oxygen therapy should be attributed to oxygen therapy as prescribed and used, not automatically to every POC.

The limits are equally clear. Device performance depends on breath detection, sieve condition, and battery state. Prescription accuracy depends on testing that many patients never receive. And no device substitutes for a clinician's judgment about whether a patient's needs fit the portable category at all.

The honest answer to whether portable oxygen concentrators work is that the engineering works, the physiology works when titrated, and the outcome evidence is thinner than the marketing implies. The difference between a device that helps and one that sits in a closet is usually the testing done before purchase, not the spec sheet after it.